Infarction of the right ventricle with or without left ventricular involvement is becoming a more commonly diagnosed entity as the tools for diagnosis and options for treatment evolve. This chapter aims to briefly discuss the pertinent topics related to the pathophysiology, diagnosis, and treatment of right ventricular myocardial infarction (RVMI). 
The incidence of right ventricular myocardial infarction co-existing with inferior wall left ventricular dysfunction ranges from 30-50%. Cases of isolated right ventricular infarction or dysfunction are very rare, with the exception of iatrogenic causes during procedures involving the heart (i.e. interventional procedures or cardiac surgery).
The right ventricle (RV) receives its arterial blood supply primarily from the right coronary artery (RCA), which arises from the right coronary cusp of the aorta. The division produces the conus artery which supplies blood flow to the right ventricular outflow tract. The sinoatrial node (SA) is also supplied by the RCA from the second division. Coursing in the atrioventricular groove, the RCA then gives off multiple, small branches to supply the anterior RV before dividing terminally into the acute marginal branch (AM) that runs anteriorly along the diaphragm, and the posterior descending artery (PDA) that runs posteriorly. The PDA also supplies the atrioventricular node (AV) in 90% of patients, with a branch of the left circumflex artery providing flow in the remainder of patients. The PDA supplies the inferior wall of both ventricles, and is a terminal branch of the RCA in 85% of patients, but may arise from the left coronary circulation in 15% of the population.
The primary effects of RV ischemia and infarction result from decreased RV contractility. This leads to a reduction in blood flow from the venous system to the lungs, and finally to the left side of the heart. The clinical signs of this are increased right sided heart pressures, increased pulmonary artery (PA) systolic pressures, and decreased left ventricular preload. Symptoms may include peripheral edema especially distention of the jugular vein, hypoxemia, and hypotension.
Additionally, as the RV dilates the motion and function of the interventricular septum is altered. If the RV is dilated secondary to overload or if the septal myocardium is jeopardized by simultaneous left ventricle (LV) ischemia the symptoms of hypotension and cardiac failure may be pronounced. If the septum shifts leftward during diastole it impedes left ventricular filling and as a result cardiac output is decreased. This is termed loss of biventricular interdependence.
Patients with RV infarction present with symptoms commonly seen in left side infarction, including chest pain with or without radiation, dyspnea, nausea, and dizziness. These patients may exhibit rhythm abnormalities ranging from bradycardia to complete heart block. Hypotension may also be more common in this population. Other signs of right heart failure such as acute peripheral edema and jugular venous distention may also be present. The triad of jugular vein distention, clear lung fields, and hypotension is the classic picture of right ventricular dysfunction. A pan-systolic murmur best heard at the left lower sternal border may indicate tricuspid regurgitation, but due to the lower filling pressures of the right heart, this is not always present.
An electrocardiogram (ECG) is the first diagnostic test performed in patients complaining of chest pain. If the left ventricle is involved, evidence of inferior lead ischemia/infarction in leads II, III, and AVF is likely to be present. Disproportionate ST-elevation in lead III>II is pathognomonic for RVMI and warrants further investigation. ST elevation in the V1 lead is also highly suspicious for RVMI and is even more specific when coupled with ST-depression in lead V2. Overall, conventional left sided electrocardiography is a poor indicator of RV ischemia/infarction due to the position of the right side of the heart. If right side dysfunction is suspected, a right-sided ECG is the most sensitive and specific, as ST elevation in V4R >1.0 mm has 100% sensitivity, 87% specificity, and 92% predictive accuracy. Conduction abnormalities such as right bundle branch block, bradycardia, or complete heart block can also manifest themselves in the ECG but may also be non-specific. 
Cardiac enzymes will be elevated in RVMI, similarly to LVMI scenarios. However, when differentiating between hemodynamically significant PE and RVMI, the picture is not as clear, as both troponin-I and CK-MB levels may be elevated in a minority of cases of significant PE.
Echocardiography has a high threshold for detecting right-sided myocardial dysfunction, and its increasing availability and fidelity has made it a rising diagnostic modality in a variety of settings such as the emergency department and the operating room. The sensitivity and specificity of echo may be as high as 82% and 93%, respectively, for detection of right ventricular infarction. Signs include right ventricular wall dyskinesia/hypokinesia, paradoxical septal motion, tricuspid regurgitation, and pulmonary regurgitation. Other measurements such as tricuspid annular plane excursion (TAPSI) are currently being evaluated and may indicate a poor prognosis.
Coronary angiography and ventricular scintigraphy are the gold standards for definitive diagnosis. These procedures are invasive, require a large use of resources, and are often performed during intervention; their place in the initial evaluation and work up are limited. Chest radiography also has limited specificity and diagnostic capability. Findings of an enlarged heart silhouette, dilation of the inferior or superior venae cavae, and clear lung fields may be present. The presence or absence of pulmonary edema may be useful in determining the presence or extent of concomitant left ventricular dysfunction or to further evaluate for the presence of a pulmonary embolus (PE).
Decreased right heart function, if clinically significant, may lead to decreased left ventricular preload, decreased cardiac output, and eventually systemic hypotension. One approach to the treatment of suspected RVMI includes administering a fluid challenge of 500 milliliters of crystalloid fluid. It is important to monitor for improvement in hemodynamics, or lack thereof, as patients may present with variable volume statuses ranging from hypovolemia to fluid overload. Treatment with nitrates may be harmful, as the ventilation and drop in preload can worsen RV dysfunction and systemic flow. 
Pharmacologic therapy with inotropic agents may be warranted if the fluid response is suboptimal. The most studied agent is dobutamine. It has been shown to improve cardiac index and RV stroke volume. Additionally, dobutamine improves left ventricular function further promoting forward flow. The combination of inhaled nitric oxide combined with dobutamine also has the added benefit of reducing pulmonary vascular resistance (PVR), thereby decreasing RV afterload and myocardial work. Milrinone, a phosphodiesterase III inhibitor, may also improve RV dysfunction. The increased cAMP levels from milrinone administration led to increased RV contractility and decreased PVR. However, milrinone is not a selective pulmonary vasodilator, and its use must be weighed against the risk of exacerbating systemic hypotension. A class of agents known as calcium sensitizers may also improve RV function, but their use is limited to European centers at this time. One such agent, levosimendan, has been shown to improve RV function. The mechanism of action involves improving cardiac contractility by increasing cardiac myocyte sensitivity to intracellular calcium without increasing calcium concentrations. The clinical effects of this drug are increased inotropy, as well as peripheral vasodilation.
Due to the location of the conduction system of the heart, arrhythmias ranging from bradycardia to complete heart block may arise in patients with RVMI. The decreased preload and relatively fixed LV stroke volume mean that systemic cardiac output is somewhat rate-dependent. Additionally, it has been shown that AV pacing in patients presenting with RVMI and complete heart block can improve survival, while ventricular pacing alone does not.
Similar to the treatment of LV infarction, time of revascularization is the primary factor dictating survival and recovery. Earlier intervention is favored in either instance. It is the only treatment modality targeted at treating the cause of RVMI, while the other treatment options mentioned here are for symptomatic management of the sequelae. The use of ventricular assist devices (VADs), both surgical and percutaneous, have been shown to improve survival, but data is limited primarily to case reports and small studies. An intra-aortic balloon pump is also a treatment option. In addition to augmenting left heart function, the elevation of diastolic flow and coronary perfusion may help improve blood flow to the right heart distribution.
Short term prognosis of patients presenting with RVMI is worse than those with isolated LVMI. Both in-hospital morbidity and mortality are increased. This is likely due to the critical complications that can occur from significant RV infarction, which may require additional invasive procedures and manipulation (i.e. placement of ICDs, placement of VADs, arrhythmias). Long-term prognosis of patients who are discharged from the hospital after treatment and resolution of RVMI is similar to that of patients with LVMI.
Diagnosis of RVMI, especially in the absence of acute hemodynamic changes or shock, requires a high threshold of suspicion. Findings from the initial evaluation of patients presenting with chest pain may not clearly show the evolving ischemia in the right heart. The possibility of other etiologies such as pulmonary embolism, pulmonary hypertension, and causes of hypovolemia may cloud the clinical picture. When possible, the employment of non-invasive diagnostic modalities such as echocardiography may help detect problems sooner than traditional tests of myocardial ischemia.
The diagnosis and management of right ventricular infarction is complex and requires a multidisciplinary team that includes a cardiologist, internist, nurse practitioner, radiologist, and an intensivist. Most of these patients have risk factors for coronary artery disease and it is imperative that healthcare workers emphasize weight control, discontinuing smoking, regular exercise, medication compliance and lowering blood cholesterol. The short term prognosis for treated patients is good but over the long term, the condition carries high morbidity and mortality. 
|||Mactier I,Dalzell JR,Carrick D, Recurrent myocardial infarction in a 50-year-old woman. Heart (British Cardiac Society). 2019 Feb 14; [PubMed PMID: 30765423]|
|||Nguyen QT,Jalloul Nsaibia M,Sirois MG,Calderone A,Tardif JC,Fen Shi Y,Ruiz M,Daneault C,Gagnon L,Grouix B,Laurin P,Dupuis J, PBI-4050 Reduces Pulmonary Hypertension, Lung fibrosis and Right Ventricular Dysfunction in Heart Failure. Cardiovascular research. 2019 Feb 7; [PubMed PMID: 30753422]|
|||Pothineni NV,Kancharla K,Katoor AJ,Shanta G,Paydak H,Kapa S,Deshmukh A, Coronary artery injury related to catheter ablation of cardiac arrhythmias: A systematic review. Journal of cardiovascular electrophysiology. 2019 Jan; [PubMed PMID: 30288838]|
|||Lo KB,Mezue K,Ram P,Goyal A,Shah M,Krishnamoorthy P,Gupta S,Pressman GS,Rangaswami J, Echocardiographic and Hemodynamic Parameters Associated with Diminishing Renal Filtration among Patients with Heart Failure with Preserved Ejection Fraction. Cardiorenal medicine. 2018 Dec 13; [PubMed PMID: 30544108]|
|||Albaghdadi A,Teleb M,Porres-Aguilar M,Porres-Munoz M,Marmol-Velez A, The dilemma of refractory hypoxemia after inferior wall myocardial infarction. Proceedings (Baylor University. Medical Center). 2018 Jan; [PubMed PMID: 29686558]|
|||Ashida T,Tani S,Nagao K,Yagi T,Matsumoto N,Hirayama A, Usefulness of synthesized 18-lead electrocardiography in the diagnosis of ST-elevation myocardial infarction: A pilot study The American journal of emergency medicine. 2017 Mar; [PubMed PMID: 27931763]|
|||Venkatachalam S,Wu G,Ahmad M, Echocardiographic assessment of the right ventricle in the current era: Application in clinical practice. Echocardiography (Mount Kisco, N.Y.). 2017 Dec; [PubMed PMID: 28833543]|
|||Konstam MA,Kiernan MS,Bernstein D,Bozkurt B,Jacob M,Kapur NK,Kociol RD,Lewis EF,Mehra MR,Pagani FD,Raval AN,Ward C, Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association. Circulation. 2018 May 15; [PubMed PMID: 29650544]|
|||Kulakowski P, Programmed ventricular stimulation early after myocardial infarction: are the guidelines right? Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2016 May; [PubMed PMID: 26857187]|
|||Bajcetic M,Uzelac TV,Jovanovic I, Heart failure pharmacotherapy: differences between adult and paediatric patients. Current medicinal chemistry. 2014; [PubMed PMID: 24606511]|
|||Tarvasmäki T,Harjola VP,Tolonen J,Siirilä-Waris K,Nieminen MS,Lassus J, Management of acute heart failure and the effect of systolic blood pressure on the use of intravenous therapies. European heart journal. Acute cardiovascular care. 2013 Sep; [PubMed PMID: 24222833]|
|||Anderson M,Morris DL,Tang D,Batsides G,Kirtane A,Hanson I,Meraj P,Kapur NK,O'Neill W, Outcomes of patients with right ventricular failure requiring short-term hemodynamic support with the Impella RP device. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2018 Dec; [PubMed PMID: 30241890]|
|||Keskin M,Uzun AO,Hayıroğlu Mİ,Kaya A,Çınar T,Kozan Ö, The association of right ventricular dysfunction with in-hospital and 1-year outcomes in anterior myocardial infarction. The international journal of cardiovascular imaging. 2019 Jan; [PubMed PMID: 30109454]|